Table 2.
Relationship between risk or COVID-19 severity factors and thromboprophylaxis doses.
| Predictors | Odds ratio | CI | P value |
|---|---|---|---|
| Age | 1.01 | .99−1.02 | .226 |
| Males | .99 | .70−1.40 | .977 |
| C-reactive protein | 1.00 | 1.00−1.01 | <.001 |
| Mechanical ventilation | 2.58 | 1.63−4.12 | <.001 |
| Recruitment manoeuvres | .84 | .49−1.46 | .521 |
| Prone sessions | 1.00 | .62−1.64 | .993 |
| Neuromuscular relaxation | 1.76 | .96−3.37 | .075 |
| Tocilizumab | 2.57 | 1.25−5.85 | .015 |
| Corticosteroids | .63 | .42−.94 | .022 |
CI: Confidence Interval.